Effective management of this symptom is critical to ensure patient safety, enhance treatment adherence, and improve quality of life
" Clinical experts and researchers have noted that 12.4% average weight loss at the highest dose places Foundayo meaningfully below the weight loss achieved with weekly injectable GLP-1 drugs
More serious symptoms, especially allergic reactions, chest pain, worsening headaches, or visual changes, should always be evaluated promptly
control group: n = 156) Publication: Reprod Biol Endocrin (Dec 2016) 14:84
2.3 Initial Weight Loss and Randomization Initially, participants completed an 8-week low-calorie diet, which consisted of four meal replacement products per day (approximately 800 kcal/day, 15 g of fat, 110 g of carbohydrates, 56 g of protein)